In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI)[1] models in drug development and in regulatory submissions titled, ...
This appendix introduces the different models of credibility theory: classical model, Buhlmann, Buhlmann–Straub, and Buhlmann–Straub for small and large losses. This section presents the classical ...
Disclaimer: This Working Paper should not be reported as representing the views of the IMF.The views expressed in this Working Paper are those of the author(s) and do not necessarily represent those ...
Anthony Battle is a CERTIFIED FINANCIAL PLANNER™ professional. He earned the Chartered Financial Consultant® designation for advanced financial planning, the Chartered Life Underwriter® designation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results